Skip to main content
Susan Eshleman, MD, Pathology, Baltimore, MD, Johns Hopkins Hospital

SusanHenriettaEshlemanMD

Pathology • Baltimore, MD

Blood Banking & Transfusion Medicine, Transplantation Immunology, Clinical Pathology

Professor of Pathology, Johns Hopkins University School of Medicine; Director, HIV Prevention Trials Network (HPTN) Network Laboratory

Join to view full profile

Are you Dr. Eshleman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 44 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Susan Eshleman, MD is a board certified pathologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and Ohio. She is affiliated with Johns Hopkins Hospital and is a Professor of Pathology at HIV Prevention Trials Network (HPTN) Network Laboratory.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1988 - 1993
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 1987 - 1988
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1987

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1997 - 2024
  • OH State Medical License
    OH State Medical License 1993 - 1998
  • American Board of Pathology Clinical Pathology
  • American Board of Pathology Blood Banking/Transfusion Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Press Mentions

  • HIV Incidence: Effect of Universal Testing and Treatment
    HIV Incidence: Effect of Universal Testing and TreatmentJuly 17th, 2019
  • HIV Status May Be Misreported by People Who Inject Drugs
    HIV Status May Be Misreported by People Who Inject DrugsJanuary 14th, 2019
  • HIV-1 Diversity Among Young Women in Rural South Africa: HPTN 068
    HIV-1 Diversity Among Young Women in Rural South Africa: HPTN 068July 5th, 2018

Grant Support

  • Impact Of Maternal Haart On Hiv-Infected Breastfeeding Infants: MalawiNational Institute Of Allergy And Infectious Diseases2010–2012
  • Laboratory And Statistical Development Of Cross-Sectional HIV Incidence AssaysNational Institute Of Allergy And Infectious Diseases2011
  • HIV Prevention Trials Network: Network LaboratoryNational Institute Of Allergy And Infectious Diseases2011
  • Resistance In Hiv-Infected Infants After Extended ARV Prophylaxis: Pepi-MalawiEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2010
  • HIV Prevention Trials Network: Network LaboratoryNational Institute Of Allergy And Infectious Diseases2006–2010
  • Drug Resistance In Non-Subtype B HIV-1Eunice Kennedy Shriver National Institute Of Child Health &Human Development2002–2005
  • V3 Region Diversity In HIV Vertical Transmission: UgandaEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–2000
  • V3 Region Diversity In HIV Vertical Transmission: UgandaEunice Kennedy Shriver National Institute Of Child Health &Human Development1996
  • Regulation Of Glycoprotein SynthesisNational Institute Of General Medical Sciences1991–1992

Hospital Affiliations

Dr. Susan Eshleman, Dr. Susan Eshleman, MD, Dr. S Eshleman, Dr. Susan Henrietta Eshleman